Roche is acquiring global rights to an experimental obesity drug developed by Rona Therapeutics. This RNA therapy could differentiate it from the weight management medicines from market leaders Eli Lilly and Novo. For the full story: https://ow.ly/kl505101x8T
#obesity #siRNA
Roche is acquiring global rights to an experimental obesity drug developed by Rona Therapeutics. This RNA therapy could differentiate it from the weight management medicines from market leaders Eli Lilly and Novo. For the full story: https://ow.ly/kl505101x8T #obesity #siRNA
0 vue
Publié le 28/10/2026 22:01
1:08
Roche is acquiring global rights to an experimental obesity drug developed by Rona Therapeutics. This RNA therapy could differentiate it from the weight management medicines from market leaders Eli Lilly and Novo. For the full story: https://ow.ly/kl505101x8T
#obesity #siRNA
0 commentaire
?